Role of Platelet-Activating Factor in Allergic Conjunctivitis
Author Information
Author(s): F. Meijer, J. L. van Delft, N. J. van Haeringen
Primary Institution: Biochemical Laboratory, the Netherlands; Ophthalmic Research Institute, Amsterdam; Department of Ophthalmology, Academic Hospital, Leiden, the Netherlands
Hypothesis
Does platelet-activating factor (PAF) mediate increased conjunctival vascular permeability in allergic conjunctivitis?
Conclusion
PAF plays a significant role in the acute phase of allergic conjunctivitis in guinea-pigs.
Supporting Evidence
- Topical application of PAF resulted in an inflammatory response including hyperaemia and conjunctival oedema.
- PAF provocation showed a dose-dependent increase in conjunctival vascular permeability.
- BN 52021 significantly inhibited the vascular permeability and clinical score after PAF challenge.
Takeaway
This study found that a substance called PAF makes the eyes swell and become red during allergies, and blocking it helps reduce these symptoms.
Methodology
Guinea-pigs were sensitized to ovalbumin and then treated with PAF or ovalbumin to measure vascular permeability and clinical scores.
Limitations
The study was conducted on guinea-pigs, which may not fully represent human responses.
Participant Demographics
Female Hartley strain guinea-pigs, weight range 350-450 g.
Statistical Information
P-Value
<0.01
Statistical Significance
p<0.01
Want to read the original?
Access the complete publication on the publisher's website